212 related articles for article (PubMed ID: 1520594)
21. Apoptosis and immunohistochemical bcl-2 expression in colorectal adenomas and carcinomas. Aspects of carcinogenesis and prognostic significance.
Baretton GB; Diebold J; Christoforis G; Vogt M; Müller C; Dopfer K; Schneiderbanger K; Schmidt M; Löhrs U
Cancer; 1996 Jan; 77(2):255-64. PubMed ID: 8625232
[TBL] [Abstract][Full Text] [Related]
22. Relationship among p53, stage, and prognosis of large bowel cancer.
Nathanson SD; Linden MD; Tender P; Zarbo RJ; Jacobsen G; Nelson LT
Dis Colon Rectum; 1994 Jun; 37(6):527-34. PubMed ID: 8200229
[TBL] [Abstract][Full Text] [Related]
23. High frequency of p53 expression in colo-rectal adenomatous polyps.
Boccuzzi A; Terzolo M; Leonardo E; Cappia S; Tappero G; Paccotti P; Angeli A
Anticancer Res; 1995; 15(4):1407-10. PubMed ID: 7654029
[TBL] [Abstract][Full Text] [Related]
24. Immunohistochemical detection of p53 tumor suppressor gene protein in canine epithelial colorectal tumors.
Wolf JC; Ginn PE; Homer B; Fox LE; Kurzman ID
Vet Pathol; 1997 Sep; 34(5):394-404. PubMed ID: 9381650
[TBL] [Abstract][Full Text] [Related]
25. 5T4 oncofetal antigen in gastric carcinoma and its clinical significance.
Starzynska T; Wiechowska-Kozlowska A; Marlicz K; Bromley M; Roberts SA; Lawniczak M; Kolodziej B; Zyluk A; Stern PL
Eur J Gastroenterol Hepatol; 1998 Jun; 10(6):479-84. PubMed ID: 9855063
[TBL] [Abstract][Full Text] [Related]
26. Expression and clinicopathologic significance of TUFM and p53 for the normal-adenoma-carcinoma sequence in colorectal epithelia.
Xi HQ; Zhang KC; Li JY; Cui JX; Zhao P; Chen L
World J Surg Oncol; 2017 Apr; 15(1):90. PubMed ID: 28449687
[TBL] [Abstract][Full Text] [Related]
27. p21(Waf1/Cip1) expression and the p53/MDM2 feedback loop in gastric carcinogenesis.
Craanen ME; Blok P; Offerhaus GJ; Meijer GA; Dekker W; Kuipers EJ; Meuwissen SG
J Pathol; 1999 Dec; 189(4):481-6. PubMed ID: 10629547
[TBL] [Abstract][Full Text] [Related]
28. Expression of p53 and flow cytometric DNA analysis of isolated neoplastic glands of the stomach: an application of the gland isolation method.
Kitayama Y; Sugimura H; Tanaka M; Nakamura S; Kino I
Virchows Arch; 1995; 426(6):557-62. PubMed ID: 7655735
[TBL] [Abstract][Full Text] [Related]
29. Immunohistological p53 staining is of limited value in the staging and prognostic prediction of colorectal cancer.
Kressner U; Lindmark G; Gerdin B; Påhlman L; Glimelius B
Anticancer Res; 1996; 16(2):951-7. PubMed ID: 8687158
[TBL] [Abstract][Full Text] [Related]
30. Correlation of p53 with the clinicopathologic features and prognosis of colorectal adenocarcinoma.
Suzuki H; Matsumoto K; Koide A; Tada T; Fujino I; Okuda A; Shigemori C
Surg Today; 1994; 24(1):85-7. PubMed ID: 8054784
[TBL] [Abstract][Full Text] [Related]
31. Prognostic influence of p53 expression in gastric cancer.
Müller W; Borchard F
J Pathol; 1996 Mar; 178(3):255-8. PubMed ID: 8778328
[TBL] [Abstract][Full Text] [Related]
32. Concordance between p53 protein overexpression and gene mutation in a large series of common human carcinomas.
Soong R; Robbins PD; Dix BR; Grieu F; Lim B; Knowles S; Williams KE; Turbett GR; House AK; Iacopetta BJ
Hum Pathol; 1996 Oct; 27(10):1050-5. PubMed ID: 8892589
[TBL] [Abstract][Full Text] [Related]
33. Prognostic significance of p53 overexpression and mutation in colorectal adenocarcinomas.
Smith DR; Ji CY; Goh HS
Br J Cancer; 1996 Jul; 74(2):216-23. PubMed ID: 8688324
[TBL] [Abstract][Full Text] [Related]
34. Clinico-pathological correlation and prognostic significance of nuclear p53 protein in colorectal cancer. Colorectal Cancer Study Group of the University and Health Care District of Modena.
Fante R; Di Gregorio C; Losi L; Roncucci L; Ponz de Leon M
Ital J Gastroenterol; 1996 May; 28(4):205-10. PubMed ID: 8842835
[TBL] [Abstract][Full Text] [Related]
35. Gastric cancer with p53 overexpression has high potential for metastasising to lymph nodes.
Kakeji Y; Korenaga D; Tsujitani S; Baba H; Anai H; Maehara Y; Sugimachi K
Br J Cancer; 1993 Mar; 67(3):589-93. PubMed ID: 8439509
[TBL] [Abstract][Full Text] [Related]
36. P21 (WAF1) expression in colorectal cancer: correlation with P53 and cyclin D1 expression, clinicopathological parameters and prognosis.
Pasz-Walczak G; Kordek R; Faflik M
Pathol Res Pract; 2001; 197(10):683-9. PubMed ID: 11700890
[TBL] [Abstract][Full Text] [Related]
37. p53 immunoreaction in endoscopic biopsy specimens of colorectal cancer, and its prognostic significance.
Yamaguchi A; Nakagawara G; Kurosaka Y; Nishimura G; Yonemura Y; Miyazaki I
Br J Cancer; 1993 Aug; 68(2):399-402. PubMed ID: 8347496
[TBL] [Abstract][Full Text] [Related]
38. Immunohistochemical expression of bcl-2 in UICC stage I and III colorectal carcinoma patients: correlation with c-erbB-2, p53, ki-67, CD44, laminin and collagen IV in evaluating prognostic significance.
Zavrides H; Zizi-Sermpetzoglou A; Elemenoglou I; Papatheofanis I; Peros G; Athanasas G; Panousopoulos D
Pol J Pathol; 2006; 57(3):149-59. PubMed ID: 17219742
[TBL] [Abstract][Full Text] [Related]
39. Prognostic value of p53 protein expression in breast carcinomas.
Hurlimann J
Pathol Res Pract; 1993 Nov; 189(9):996-1003. PubMed ID: 8302733
[TBL] [Abstract][Full Text] [Related]
40. p53 protein expression in ulcerative colitis-associated colorectal dysplasia and carcinoma.
Harpaz N; Peck AL; Yin J; Fiel I; Hontanosas M; Tong TR; Laurin JN; Abraham JM; Greenwald BD; Meltzer SJ
Hum Pathol; 1994 Oct; 25(10):1069-74. PubMed ID: 7927312
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
